Dr Jade Murray, Postdoctoral Research Fellow
Turner Institute for Brain and Mental Health, Monash University
VICTORIA, AUSTRALIA
Bench Side Story continues with a Postdoctoral Research Fellow at the Turner Institute for Brain and Mental Health, at Monash University in Melbourne, Victoria, AUSTRALIA.
Dr. Jade M. Murray completed a PhD programme at the Monash University Sleep and Circadian Medicine Laboratory in 2018. Dr. Murray’s broad research interests include studying the effects of circadian misalignment on overall health in both healthy and sleep disordered populations and developing simplified methods for determining the timing of circadian phase. An important innovation in her work has been tracking light-dark exposure data over time to build predictive models of circadian timing for development of personalised delivery systems for sleep-wake interventions to improve health and lifestyle outcomes.
-
Dr Ryan O’Hare Doig
NEIL SACHSE CENTRE FOR SPINAL CORD RESEARCH (SAHMRI)
SOUTH AUSTRALIA
AUSTRALIA -
Biomarkers for early sepsis detection
Dr Gabrielle Briggs is a biomedical scientist dedicated to finding smarter, faster ways to diagnose and treat life threatening complications in critically ill patients. Dr Briggs established a research laboratory embedded within the John Hunter Hospital – one of the busiest major trauma centres in NSW. Dr Briggs works alongside surgeons, intensivists, and pathologists to turn complex clinical problems into practical research solutions. Her work spans two major programs: developing a rapid diagnostic test to detect bacterial infections in blood before sepsis takes hold, and exploring mitochondrial transplantation as a novel therapy to rescue injured tissues after trauma and ischaemia.
-
Neonatal respiratory trials in sick & preterm newborn infants
Prof Brett J. Manley leads and collaborates on large national and international randomised clinical trials in neonatology. He previously collaborated on 4 randomised trials of nasal high-flow as non-invasive respiratory support for preterm and term infants, all of which were published in N Engl J Med. Recently he led the PLUSS trial of intratracheal budesonide for extremely preterm infants, that recruited in 21 NICUs across 4 countries, the results of which were published in JAMA. PLUSS was awarded the Australian Clinical Trials Alliance Trial of the Year in 2025. Another passion of his is mentoring and supervising early career researchers to undertake their own clinical trials.
